NYSE:USPH (USA) Also trade in: Germany

US Physical Therapy Inc

$ 120.45 0.49 (0.41%)
Volume: 92,078 Avg Vol (1m): 91,215
Market Cap $: 1.54 Bil Enterprise Value $: 1.55 Bil
P/E (TTM): 84.23 P/B: 6.99
Earnings Power Value 34.16
Net Current Asset Value -17.48
Tangible Book -9.58
Projected FCF 59.95
Median P/S Value 52.41
Graham Number 0
Peter Lynch Value 10.93
DCF (FCF Based) 61.68
DCF (Earnings Based) 15.3
1Y (-%)

Financial Strength : 7/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.66
Cash-To-Debt ranked higher than
50.00% of 274 companies
in the Medical Care industry.
Industry Max: 10000, Med: 0.28, Min: 0.01
USPH: 0.66
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0.17, Med: 0.68, Max: 10000
Current: 0.66
0.17
10000
Equity-to-Asset 0.42
Equity-to-Asset ranked higher than
51.67% of 269 companies
in the Medical Care industry.
Industry Max: 0.97, Med: 0.48, Min: -15.93
USPH: 0.42
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: 0.27, Med: 0.65, Max: 0.97
Current: 0.42
0.27
0.97
Debt-to-Equity 0.14
Debt-to-Equity ranked higher than
72.28% of 202 companies
in the Medical Care industry.
Industry Max: 25.64, Med: 0.64, Min: 0.01
USPH: 0.14
Ranked among companies with meaningful Debt-to-Equity only.
Debt-to-Equity range over the past 10 years
Min: 0, Med: 0.23, Max: 2.18
Current: 0.14
0
2.18
Debt-to-EBITDA 0.41
Debt-to-EBITDA ranked higher than
79.10% of 201 companies
in the Medical Care industry.
Industry Max: 66.84, Med: 2.81, Min: 0.01
USPH: 0.41
Ranked among companies with meaningful Debt-to-EBITDA only.
Debt-to-EBITDA range over the past 10 years
Min: 0.04, Med: 0.63, Max: 0.94
Current: 0.41
0.04
0.94
Interest Coverage 33.94
Interest Coverage ranked lower than
70.48% of 227 companies
in the Medical Care industry.
Industry Max: 48765, Med: 6.85, Min: 0.01
USPH: 33.94
Ranked among companies with meaningful Interest Coverage only.
Interest Coverage range over the past 10 years
Min: 2.6, Med: 46.45, Max: 140.64
Current: 33.94
2.6
140.64
Piotroski F-Score 7
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.70
DISTRESS
GREY
SAFE
Beneish M-Score -2.73
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 21.49%
WACC 10.44%

Profitability & Growth : 9/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 13.57
Operating Margin ranked higher than
69.49% of 272 companies
in the Medical Care industry.
Industry Max: 66.83, Med: 6.83, Min: -3742
USPH: 13.57
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: 13.22, Med: 14.16, Max: 15.71
Current: 13.57
13.22
15.71
Net Margin % 7.84
Net Margin ranked higher than
57.35% of 272 companies
in the Medical Care industry.
Industry Max: 202.55, Med: 3.88, Min: -4897.7
USPH: 7.84
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: 4.82, Med: 6.25, Max: 9.06
Current: 7.84
4.82
9.06
ROE % 8.55
ROE ranked higher than
60.78% of 255 companies
in the Medical Care industry.
Industry Max: 73.04, Med: 8.03, Min: -4811.69
USPH: 8.55
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: 7.89, Med: 13.46, Max: 19.88
Current: 8.55
7.89
19.88
ROA % 7.94
ROA ranked higher than
64.10% of 273 companies
in the Medical Care industry.
Industry Max: 52.42, Med: 3.48, Min: -3383.78
USPH: 7.94
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: 5.78, Med: 8.13, Max: 13.79
Current: 7.94
5.78
13.79
ROC (Joel Greenblatt) % 219.17
ROC (Joel Greenblatt) ranked higher than
89.34% of 272 companies
in the Medical Care industry.
Industry Max: 8470.37, Med: 14.91, Min: -33236.56
USPH: 219.17
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: 96.79, Med: 124.13, Max: 219.17
Current: 219.17
96.79
219.17
3-Year Total Revenue Growth Rate 11.10
3-Year Revenue Growth Rate ranked higher than
64.45% of 211 companies
in the Medical Care industry.
Industry Max: 314.7, Med: 6.5, Min: -100
USPH: 10.3
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: 7.1, Med: 12.7, Max: 181.8
Current: 10.3
7.1
181.8
3-Year Total EBITDA Growth Rate 9.20
3-Year EBITDA Growth Rate ranked higher than
58.70% of 184 companies
in the Medical Care industry.
Industry Max: 236.4, Med: 5.9, Min: -108
USPH: 8.4
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
3-Year EBITDA Growth Rate range over the past 10 years
Min: 0, Med: 8.2, Max: 30.9
Current: 8.4
0
30.9
3-Year EPS w/o NRI Growth Rate -7.60
3-Year EPS w/o NRI Growth Rate ranked lower than
58.02% of 162 companies
in the Medical Care industry.
Industry Max: 136.6, Med: 8.4, Min: -146.6
USPH: -7.6
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 7.6, Max: 127
Current: -7.6
0
127

» USPH's 30-Y Financials

Financials (Next Earnings Date: 2019-08-02)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:USPH

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Health Care Providers » Medical Care    NAICS : 621498    SIC : 8093
Compare BKK:SVH SGX:A50 BOM:532843 SGX:BSL BKK:BCH-F ASX:HLS BKK:RAM OHEL:TTALO TSE:7716 SZSE:000950 SZSE:000150 BOM:540975 NAS:TVTY XKLS:5878 XTER:RHK SAU:4004 NYSE:SEM HKSE:01515 TSE:6197 NAS:ADUS
Traded in other countries UPH.Germany
Address 1300 West Sam Houston Parkway South, Suite 300, Houston, TX, USA, 77042
US Physical Therapy Inc operates outpatient physical therapy and occupational therapy clinics throughout the United States. Its clinics provide treatment for orthopedic disorders, sports-related injuries, and work-related injuries. The company also administers care designed to prevent injuries from occurring. At the start of 2002, the company operated 170 clinics in more than 30 states.

Ratios

Current vs industry vs history
PE Ratio (TTM) 84.23
PE Ratio ranked lower than
79.29% of 198 companies
in the Medical Care industry.
Industry Max: 6430, Med: 27.31, Min: 1.39
USPH: 84.23
Ranked among companies with meaningful PE Ratio only.
PE Ratio range over the past 10 years
Min: 8.91, Med: 24.55, Max: 88.62
Current: 84.23
8.91
88.62
Forward PE Ratio 42.02
Forward P/E ranked lower than
79.66% of 59 companies
in the Medical Care industry.
Industry Max: 107.53, Med: 20.66, Min: 8.31
USPH: 42.02
Ranked among companies with meaningful Forward P/E only.
N/A
PE Ratio without NRI 84.23
PE without NRI ranked lower than
79.80% of 198 companies
in the Medical Care industry.
Industry Max: 6430, Med: 9999, Min: 1.39
USPH: 84.23
Ranked among companies with meaningful PE without NRI only.
PE without NRI range over the past 10 years
Min: 8.91, Med: 22.4, Max: 88.62
Current: 84.23
8.91
88.62
Price-to-Owner-Earnings 38.05
Price-to-Owner-Earnings ranked lower than
61.47% of 109 companies
in the Medical Care industry.
Industry Max: 8000, Med: 26.64, Min: 1.5
USPH: 38.05
Ranked among companies with meaningful Price-to-Owner-Earnings only.
Price-to-Owner-Earnings range over the past 10 years
Min: 5.5, Med: 20.65, Max: 40.73
Current: 38.05
5.5
40.73
PB Ratio 6.99
PB Ratio ranked lower than
81.03% of 253 companies
in the Medical Care industry.
Industry Max: 48, Med: 2.64, Min: 0.05
USPH: 6.99
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 1.12, Med: 3.04, Max: 7.69
Current: 6.99
1.12
7.69
PS Ratio 3.32
PS Ratio ranked lower than
64.89% of 262 companies
in the Medical Care industry.
Industry Max: 79.41, Med: 1.7, Min: 0.03
USPH: 3.32
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 0.49, Med: 1.44, Max: 3.64
Current: 3.32
0.49
3.64
Price-to-Free-Cash-Flow 24.37
Price-to-Free-Cash-Flow ranked lower than
52.59% of 135 companies
in the Medical Care industry.
Industry Max: 777.22, Med: 23.01, Min: 1.25
USPH: 24.37
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
Price-to-Free-Cash-Flow range over the past 10 years
Min: 3.33, Med: 10.53, Max: 27.32
Current: 24.37
3.33
27.32
Price-to-Operating-Cash-Flow 21.51
Price-to-Operating-Cash-Flow ranked lower than
69.35% of 186 companies
in the Medical Care industry.
Industry Max: 1706.9, Med: 14.67, Min: 0.7
USPH: 21.51
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 2.83, Med: 9.3, Max: 24.32
Current: 21.51
2.83
24.32
EV-to-EBIT 23.97
EV-to-EBIT ranked lower than
50.47% of 214 companies
in the Medical Care industry.
Industry Max: 3101.61, Med: 21.68, Min: 1.06
USPH: 23.97
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: 3.9, Med: 10.9, Max: 28.5
Current: 23.97
3.9
28.5
EV-to-EBITDA 20.82
EV-to-EBITDA ranked lower than
60.53% of 228 companies
in the Medical Care industry.
Industry Max: 1827.89, Med: 15.23, Min: 0.9
USPH: 20.82
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: 3.1, Med: 9.55, Max: 24.3
Current: 20.82
3.1
24.3
EV-to-Revenue 3.37
EV-to-Revenue ranked lower than
60.52% of 271 companies
in the Medical Care industry.
Industry Max: 158.19, Med: 2.17, Min: 0.06
USPH: 3.37
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 0.5, Med: 1.6, Max: 3.7
Current: 3.37
0.5
3.7
PEG Ratio 9.84
PEG Ratio ranked lower than
83.51% of 97 companies
in the Medical Care industry.
Industry Max: 497.4, Med: 3.13, Min: 0.11
USPH: 9.84
Ranked among companies with meaningful PEG Ratio only.
PEG Ratio range over the past 10 years
Min: 0.83, Med: 3.09, Max: 11.35
Current: 9.84
0.83
11.35
Shiller PE Ratio 74.02
Shiller PE Ratio ranked lower than
72.58% of 62 companies
in the Medical Care industry.
Industry Max: 1305.92, Med: 31.76, Min: 8.18
USPH: 74.02
Ranked among companies with meaningful Shiller PE Ratio only.
Shiller PE Ratio range over the past 10 years
Min: 12.56, Med: 29.64, Max: 81.33
Current: 74.02
12.56
81.33
Current Ratio 1.18
Current Ratio ranked higher than
72.69% of 260 companies
in the Medical Care industry.
Industry Max: 13.59, Med: 1.34, Min: 0.04
USPH: 1.18
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 1.18, Med: 4.4, Max: 42
Current: 1.18
1.18
42
Quick Ratio 1.18
Quick Ratio ranked higher than
74.62% of 260 companies
in the Medical Care industry.
Industry Max: 13.59, Med: 1.24, Min: 0.04
USPH: 1.18
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 1.18, Med: 4.4, Max: 42
Current: 1.18
1.18
42
Days Sales Outstanding 38.29
Days Sales Outstanding ranked lower than
59.91% of 227 companies
in the Medical Care industry.
Industry Max: 524.5, Med: 39.87, Min: 0.25
USPH: 38.29
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 35.99, Med: 41.85, Max: 47.21
Current: 38.29
35.99
47.21
Days Payable 1.94
Days Payable ranked lower than
97.73% of 176 companies
in the Medical Care industry.
Industry Max: 1871.61, Med: 40.58, Min: 1
USPH: 1.94
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 1.94, Med: 2.88, Max: 3.76
Current: 1.94
1.94
3.76

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 0.82
Trailing Dividend Yield ranked lower than
79.28% of 251 companies
in the Medical Care industry.
Industry Max: 1324.37, Med: 1.79, Min: 0.07
USPH: 0.82
Ranked among companies with meaningful Trailing Dividend Yield only.
Trailing Dividend Yield range over the past 10 years
Min: 0.31, Med: 1.17, Max: 1.74
Current: 0.82
0.31
1.74
Dividend Payout Ratio 0.67
Dividend Payout Ratio ranked higher than
77.42% of 155 companies
in the Medical Care industry.
Industry Max: 21.34, Med: 0.43, Min: 0.03
USPH: 0.67
Ranked among companies with meaningful Dividend Payout Ratio only.
Dividend Payout Ratio range over the past 10 years
Min: 0.2, Med: 0.33, Max: 0.7
Current: 0.67
0.2
0.7
3-Year Dividend Growth Rate (Per Share) 15.30
3-Year Dividend Growth Rate ranked higher than
72.94% of 85 companies
in the Medical Care industry.
Industry Max: 96.1, Med: 8.7, Min: -100
USPH: 15.3
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
3-Year Dividend Growth Rate range over the past 10 years
Min: 0, Med: 0, Max: 19.3
Current: 15.3
0
19.3
Forward Dividend Yield % 0.90
Forward Dividend Yield ranked lower than
75.70% of 251 companies
in the Medical Care industry.
Industry Max: 9.57, Med: 1.99, Min: 0.12
USPH: 0.9
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield-on-Cost (5-Year) % 1.88
Yield-on-Cost (5y) ranked lower than
55.08% of 325 companies
in the Medical Care industry.
Industry Max: 1324.37, Med: 2.24, Min: 0.03
USPH: 1.88
Ranked among companies with meaningful Yield-on-Cost (5y) only.
Yield-on-Cost (5y) range over the past 10 years
Min: 0.71, Med: 2.69, Max: 4
Current: 1.88
0.71
4
3-Year Share Buyback Rate -0.70
3-Year Share Buyback Rate ranked higher than
96.23% of 159 companies
in the Medical Care industry.
Industry Max: 100, Med: -2.5, Min: -549.3
USPH: -0.7
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -9.8, Med: -0.9, Max: 7.7
Current: -0.7
-9.8
7.7

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 2.01
Price-to-Intrinsic-Value-Projected-FCF ranked higher than
58.42% of 101 companies
in the Medical Care industry.
Industry Max: 20.14, Med: 1.98, Min: 0.07
USPH: 2.01
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.39, Med: 1.02, Max: 9.21
Current: 2.01
0.39
9.21
Price-to-DCF (Earnings Based) 7.87
Price-to-Intrinsic-Value-DCF (Earnings Based) ranked lower than
84.85% of 33 companies
in the Medical Care industry.
Industry Max: 6.43, Med: 1.81, Min: 0.5
USPH: 7.87
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
Price-to-Intrinsic-Value-DCF (Earnings Based) range over the past 10 years
Min: 0.4, Med: 1.05, Max: 7.3
Current: 7.87
0.4
7.3
Price-to-Median-PS-Value 2.30
Price-to-Median-PS-Value ranked lower than
91.83% of 208 companies
in the Medical Care industry.
Industry Max: 12, Med: 1.03, Min: 0.01
USPH: 2.3
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.43, Med: 1.02, Max: 14.08
Current: 2.3
0.43
14.08
Price-to-Peter-Lynch-Fair-Value 11.02
Price-to-Peter-Lynch-Fair-Value ranked lower than
92.73% of 55 companies
in the Medical Care industry.
Industry Max: 23.11, Med: 2.08, Min: 0.48
USPH: 11.02
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 0.47, Med: 1.71, Max: 11.18
Current: 11.02
0.47
11.18
Earnings Yield (Joel Greenblatt) % 4.15
Earnings Yield (Greenblatt) ranked higher than
60.44% of 273 companies
in the Medical Care industry.
Industry Max: 94.34, Med: 3.61, Min: -217.39
USPH: 4.15
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: 3.5, Med: 9.1, Max: 25.9
Current: 4.15
3.5
25.9
Forward Rate of Return (Yacktman) % 10.76
Forward Rate of Return ranked higher than
58.65% of 133 companies
in the Medical Care industry.
Industry Max: 868.48, Med: 9.1, Min: -81.77
USPH: 10.76
Ranked among companies with meaningful Forward Rate of Return only.
Forward Rate of Return range over the past 10 years
Min: 10.5, Med: 15.1, Max: 26.9
Current: 10.76
10.5
26.9

More Statistics

Revenue (TTM) (Mil) $ 461.8
EPS (TTM) $ 1.43
Beta 1.38
Volatility % 33.18
52-Week Range $ 93 - 129.65
Shares Outstanding (Mil) 12.76

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 7
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy Y